Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1995 Nov;40(5):439–443.

Ceftazidime pharmacokinetics in preterm infants: effect of postnatal age and postnatal exposure to indomethacin.

J N van den Anker 1, W C Hop 1, R C Schoemaker 1, B J van der Heijden 1, H J Neijens 1, R de Groot 1
PMCID: PMC1365189  PMID: 8703647

Abstract

1. The effects of postnatal age and postnatal exposure to indomethacin on the pharmacokinetic parameters of ceftazidime (CAZ) were investigated in 23 preterm infants (gestational age 28.7 +/- 1.7 weeks; weight 1086 +/- 311 g) on day 3 and day 10 after birth. 2. CAZ (25 mg kg-1) was administered by intravenous bolus injection. Blood samples were drawn from an arterial catheter at 0, 0.5, 1, 2, 4, 8, and 12 h after the dose and CAZ concentrations in serum were determined by h.p.l.c. CAZ pharmacokinetics followed a one-compartment open model. 3. The glomerular filtration rate (GFR) of all infants was studied by means of the 24 h continuous inulin infusion technique. 4. The total body clearance of CAZ (34.7 +/- 9.2 vs 50.6 +/- 19.6 ml h-1, P < 0.05; 30.7 +/- 5.9 vs 41.6 +/- 9.0 ml h-1 kg-1, P < 0.05) and GFR (0.72 +/- 0.11 vs 0.91 +/- 0.15 ml min-1, P < 0.05) increased, whereas the apparent volume of distribution (425 +/- 147 vs 352 +/- 108 ml, P < 0.05; 363 +/- 59 vs 292 +/- 44 ml kg-1, P < 0.005) and the elimination half-life (8.7 +/- 2.8 vs 5.0 +/- 0.9 h, P < 0.005) decreased significantly between day 3 and day 10 after birth. Clearance of CAZ increased with increasing GFR (r = 0.81, P < 0.001). 5. In infants with postnatal exposure to indomethacin the changes in CAZ pharmacokinetics were markedly reduced. 6. These results indicate that the dosage regimen of CAZ should be adjusted after the first week of life except in infants who were postnatally exposed to indomethacin.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abstracts. Swiss Society of Nephrology. Lucerne, Switzerland, December 6, 1985. Kidney Int. 1986 Sep;30(3):453–459. [PubMed] [Google Scholar]
  2. Al-Dahhan J., Haycock G. B., Chantler C., Stimmler L. Sodium homeostasis in term and preterm neonates. I. Renal aspects. Arch Dis Child. 1983 May;58(5):335–342. doi: 10.1136/adc.58.5.335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aperia A., Broberger O., Elinder G., Herin P., Zetterström R. Postnatal development of renal function in pre-term and full-term infants. Acta Paediatr Scand. 1981 Mar;70(2):183–187. doi: 10.1111/j.1651-2227.1981.tb05539.x. [DOI] [PubMed] [Google Scholar]
  4. Arant B. S., Jr Developmental patterns of renal functional maturation compared in the human neonate. J Pediatr. 1978 May;92(5):705–712. doi: 10.1016/s0022-3476(78)80133-4. [DOI] [PubMed] [Google Scholar]
  5. Aujard Y., Brion F., Jacqz-Aigrain E., Kasse M. C., Chretien P., Criqui C., Mathieu H. Pharmacokinetics of cefotaxime and desacetylcefotaxime in the newborn. Diagn Microbiol Infect Dis. 1989 Jan-Feb;12(1):87–91. doi: 10.1016/0732-8893(89)90051-5. [DOI] [PubMed] [Google Scholar]
  6. Boccazzi A., Rizzo M., Caccamo M. L., Assael B. M. Comparison of the concentrations of ceftazidime in the serum of newborn infants after intravenous and intramuscular administration. Antimicrob Agents Chemother. 1983 Dec;24(6):955–956. doi: 10.1128/aac.24.6.955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Coulthard M. G. Maturation of glomerular filtration in preterm and mature babies. Early Hum Dev. 1985 Sep;11(3-4):281–292. doi: 10.1016/0378-3782(85)90082-9. [DOI] [PubMed] [Google Scholar]
  8. Dubowitz L. M., Dubowitz V., Goldberg C. Clinical assessment of gestational age in the newborn infant. J Pediatr. 1970 Jul;77(1):1–10. doi: 10.1016/s0022-3476(70)80038-5. [DOI] [PubMed] [Google Scholar]
  9. Fawer C. L., Torrado A., Guignard J. P. Maturation of renal function in full-term and premature neonates. Helv Paediatr Acta. 1979 Feb;34(1):11–21. [PubMed] [Google Scholar]
  10. Heimler R., Doumas B. T., Jendrzejczak B. M., Nemeth P. B., Hoffman R. G., Nelin L. D. Relationship between nutrition, weight change, and fluid compartments in preterm infants during the first week of life. J Pediatr. 1993 Jan;122(1):110–114. doi: 10.1016/s0022-3476(05)83502-4. [DOI] [PubMed] [Google Scholar]
  11. Kacet N., Roussel-Delvallez M., Gremillet C., Dubos J. P., Storme L., Lequien P. Pharmacokinetic study of piperacillin in newborns relating to gestational and postnatal age. Pediatr Infect Dis J. 1992 May;11(5):365–369. doi: 10.1097/00006454-199205000-00005. [DOI] [PubMed] [Google Scholar]
  12. Kenyon C. F., Knoppert D. C., Lee S. K., Vandenberghe H. M., Chance G. W. Amikacin pharmacokinetics and suggested dosage modifications for the preterm infant. Antimicrob Agents Chemother. 1990 Feb;34(2):265–268. doi: 10.1128/aac.34.2.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Leake R. D., Trygstad C. W., Oh W. Inulin clearance in the newborn infant: relationship to gestational and postnatal age. Pediatr Res. 1976 Aug;10(8):759–762. doi: 10.1203/00006450-197608000-00013. [DOI] [PubMed] [Google Scholar]
  14. Low D. C., Bissenden J. G., Wise R. Ceftazidime in neonatal infections. Arch Dis Child. 1985 Apr;60(4):360–364. doi: 10.1136/adc.60.4.360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. McCracken G. H., Jr, Threlkeld N., Thomas M. L. Pharmacokinetics of ceftazidime in newborn infants. Antimicrob Agents Chemother. 1984 Oct;26(4):583–584. doi: 10.1128/aac.26.4.583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Mulhall A., de Louvois J. The pharmacokinetics and safety of ceftazidime in the neonate. J Antimicrob Chemother. 1985 Jan;15(1):97–103. doi: 10.1093/jac/15.1.97. [DOI] [PubMed] [Google Scholar]
  17. Prinsloo J. G., Delport S. D., Moncrieff J., Paton A. M. A preliminary pharmacokinetic study of ceftazidime in premature, new born and small infants. J Antimicrob Chemother. 1983 Jul;12 (Suppl A):361–364. doi: 10.1093/jac/12.suppl_a.361. [DOI] [PubMed] [Google Scholar]
  18. Prober C. G., Stevenson D. K., Benitz W. E. The use of antibiotics in neonates weighing less than 1200 grams. Pediatr Infect Dis J. 1990 Feb;9(2):111–121. doi: 10.1097/00006454-199002000-00009. [DOI] [PubMed] [Google Scholar]
  19. van den Anker J. N., Hop W. C., de Groot R., van der Heijden B. J., Broerse H. M., Lindemans J., Sauer P. J. Effects of prenatal exposure to betamethasone and indomethacin on the glomerular filtration rate in the preterm infant. Pediatr Res. 1994 Nov;36(5):578–581. doi: 10.1203/00006450-199411000-00006. [DOI] [PubMed] [Google Scholar]
  20. van den Anker J. N., de Groot R., van der Heijden B. J. Use of antibiotics in neonates weighing less than 1200 g. Pediatr Infect Dis J. 1990 Oct;9(10):752–753. [PubMed] [Google Scholar]
  21. van der Heijden A. J., Grose W. F., Ambagtsheer J. J., Provoost A. P., Wolff E. D., Sauer P. J. Glomerular filtration rate in the preterm infant: the relation to gestational and postnatal age. Eur J Pediatr. 1988 Oct;148(1):24–28. doi: 10.1007/BF00441807. [DOI] [PubMed] [Google Scholar]
  22. vd Wagen A., Okken A., Zweens J., Zijlstra W. G. Composition of postnatal weight loss and subsequent weight gain in small for dates newborn infants. Acta Paediatr Scand. 1985 Jan;74(1):57–61. doi: 10.1111/j.1651-2227.1985.tb10921.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES